scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

Rhea-AI Summary

scPharmaceuticals Inc. (Nasdaq: SCPH) announced that John Tucker, its President & CEO, will present virtually at the SVB Securities Global Biopharma Conference on February 16, 2023, at 11:20 am ET. During this conference, Tucker will also engage in one-on-one meetings with investors. The company focuses on optimizing infused therapies and reducing healthcare costs, particularly through self-administrable treatments for heart failure and infectious diseases. Headquartered in Burlington, MA, scPharmaceuticals aims to enhance outpatient care while improving health outcomes.

BURLINGTON, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, President & Chief Executive Officer, is scheduled to present virtually at the SVB Securities Global Biopharma Conference, on Thursday, February 16 at 11:20 am ET. Mr. Tucker will also be meeting virtually with investors on that day.

To arrange a one-on-one meeting, please contact your SVB Securities representative.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

FAQ

When is scPharmaceuticals presenting at the SVB Securities Global Biopharma Conference?

scPharmaceuticals will present on February 16, 2023, at 11:20 am ET.

Who is presenting for scPharmaceuticals at the conference?

John Tucker, the President & CEO, will be presenting.

What is the focus of scPharmaceuticals?

scPharmaceuticals focuses on developing products for optimized delivery of infused therapies to reduce healthcare costs.

Where is scPharmaceuticals headquartered?

scPharmaceuticals is headquartered in Burlington, Massachusetts.

What type of treatments does scPharmaceuticals develop?

scPharmaceuticals develops self-administrable treatments for heart failure and infectious diseases.